{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:47:56Z","timestamp":1777870076895,"version":"3.51.4"},"reference-count":32,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"unspecified","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Insulet France SAS","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2026,4,17]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tubeless insulin pumps, introduced in France in 2016, have been associated with higher user satisfaction than tubed pumps, primarily due to reduced interference with daily tasks. Whether this translates to greater treatment persistence remains uncertain. This study evaluates persistence among people with type 1 diabetes initiating tubed or tubeless pump therapy in France.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This real-world, retrospective study used data from the French National Health Data System, a comprehensive medical claims database for the entire French population from 2016 to 2021. Treatment persistence was assessed using Kaplan-Meier curves and Cox models. Changes from one pump type to another were compared across calendar years using \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      tests.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1\u2009241\u2009624 people with insulin claims, 233\u2009874 had type 1 diabetes. Of these, 39% (n=90\u2009362) initiated insulin therapy during the study period; 32% started and remained on multiple daily injections (excluded), and 68% initiated pump therapy. Among pump users (n=61\u2009251), 51% used a tubed pump, 67% a tubeless pump, and 18% initiated both types sequentially. People initiating tubeless compared with tubed pumps had higher persistence rates (unadjusted HR 0.60, 95% CI 0.58 to 0.61) and a 40% lower risk of discontinuation (p&lt;0.0001), consistent with the adjusted model (HR 0.59, 95% CI 0.57 to 0.61). Tubeless pumps were also associated with fewer changes from one therapy to another within 12 months. Treatment changes rose for tubed pump users after tubeless pumps entered the French market.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Higher persistence and lower therapy changes among tubeless pump users underscore its sustained benefit for diabetes management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2025-005860","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:20:34Z","timestamp":1777562434000},"page":"e005860","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Tubed or tubeless insulin pumps? A retrospective real-world analysis of national French health data"],"prefix":"10.1136","volume":"14","author":[{"given":"Helene","family":"Hanaire","sequence":"first","affiliation":[{"name":"Department of Diabetes, Metabolic Disease and Nutrition, Toulouse University Hospital, University of Toulouse, France, Toulouse, Occitanie, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1413-1151","authenticated-orcid":false,"given":"Alexandre","family":"Vimont","sequence":"additional","affiliation":[{"name":"Real World Evidence, Public Health Expertise, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Bonin","sequence":"additional","affiliation":[{"name":"Insulet France SAS, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Guigand","sequence":"additional","affiliation":[{"name":"Insulet France SAS, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Hopley","sequence":"additional","affiliation":[{"name":"Insulet International, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan","family":"Catargi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology ad Metabolic Diseases, H\u00f4pital Saint-Andr\u00e9, Bordeaux University Hospital, Bordeaux, France, Pessac, Nouvelle-Aquitaine, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"2026043008201203000_14.2.e005860.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.02.023"},{"key":"2026043008201203000_14.2.e005860.2","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 . Syst\u00e8mes de mesure du glucose interstitiel, coupl\u00e9s ou non \u00e0 une pompe \u00e0 insuline, et syst\u00e8mes de boucle semi-ferm\u00e9e pour la gestion automatis\u00e9e du diab\u00e8te. 2024."},{"key":"2026043008201203000_14.2.e005860.3","unstructured":"Sant\u00e9 Publique France . Le diab\u00e8te en france continue de progresser. 2024. Available: https:\/\/www.santepubliquefrance.fr\/les-actualites\/2024\/le-diabete-en-france-continue-de-progresser#block-673712"},{"key":"2026043008201203000_14.2.e005860.4","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S006"},{"key":"2026043008201203000_14.2.e005860.5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12933-020-01200-7","article-title":"Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications","volume":"20","author":"Sun","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2026043008201203000_14.2.e005860.6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/dia.2023.0038","article-title":"Prevalence of and Reasons for Discontinuation of Continuous Subcutaneous Insulin Infusion in People with Type 1 Diabetes: A Systematic Review","volume":"25","author":"Dekker","year":"2023","journal-title":"Diabetes Technology & Therapeutics"},{"key":"2026043008201203000_14.2.e005860.7","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0345"},{"key":"2026043008201203000_14.2.e005860.8","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/ebch.623","article-title":"Cochrane review: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus","volume":"5","author":"Misso","year":"2010","journal-title":"Evid\u2010Based Child Health"},{"key":"2026043008201203000_14.2.e005860.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-0974-3"},{"key":"2026043008201203000_14.2.e005860.10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12020-016-1039-x","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis","volume":"55","author":"Benkhadra","year":"2017","journal-title":"Endocrine"},{"key":"2026043008201203000_14.2.e005860.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2007.02346.x"},{"key":"2026043008201203000_14.2.e005860.12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.amjms.2019.08.008","article-title":"Insulin Pumps: Review of Technological Advancement in Diabetes Management","volume":"358","author":"Sora","year":"2019","journal-title":"Am J Med Sci"},{"key":"2026043008201203000_14.2.e005860.13","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-010-0004-6"},{"key":"2026043008201203000_14.2.e005860.14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s13300-024-01682-8","article-title":"Experience of People with Diabetes Treated with Insulin Delivery Systems in France: A Comparative Analysis of Multiple Daily Injections, Tubeless Pumps, Tubed Pumps, and Hybrid Closed Loops","volume":"16","author":"Beltrand","year":"2025","journal-title":"Diabetes Ther"},{"key":"2026043008201203000_14.2.e005860.15","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: From the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65 Suppl 4","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"2026043008201203000_14.2.e005860.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2014.11.009"},{"key":"2026043008201203000_14.2.e005860.17","unstructured":"Sant\u00e9 Publique France . Echantillon national t\u00e9moin repr\u00e9sentatif des personnes diab\u00e9tiques, entred 2007-2010. 2013."},{"key":"2026043008201203000_14.2.e005860.18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/dia.2020.0675","article-title":"Declining Frequency of Acute Complications Associated with Tubeless Insulin Pump Use: Data from 2,911 Patients in the German\/Austrian Diabetes Patienten Verlaufsdokumentation Registry","volume":"23","author":"Biester","year":"2021","journal-title":"Diabetes Technology & Therapeutics"},{"key":"2026043008201203000_14.2.e005860.19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1089\/dia.2018.0309","article-title":"Comparing Insulin Pump Devices in Real Life: The AWeSoMe Study Group Prospective Experience","volume":"21","author":"Rachmiel","year":"2019","journal-title":"Diabetes Technology & Therapeutics"},{"key":"2026043008201203000_14.2.e005860.20","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s13300-025-01814-8","article-title":"Tubeless Insulin Pump Combined with a Cloud-Based Data Management Platform: Real-World Evidence from 14,765 French People with Diabetes","volume":"16","author":"Jeandidier","year":"2025","journal-title":"Diabetes Ther"},{"key":"2026043008201203000_14.2.e005860.21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/dom.13946","article-title":"The importance of the initial period of basal insulin titration in people with diabetes","volume":"22","author":"Khunti","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"2026043008201203000_14.2.e005860.22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s13300-023-01366-9","article-title":"Improvements in Glycemic Outcomes in 4738 Children, Adolescents, and Adults with Type 1 Diabetes Initiating a Tubeless Insulin Management System","volume":"14","author":"Aleppo","year":"2023","journal-title":"Diabetes Ther"},{"key":"2026043008201203000_14.2.e005860.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016587","article-title":"Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review","volume":"7","author":"Farsani","year":"2017","journal-title":"BMJ Open"},{"key":"2026043008201203000_14.2.e005860.24","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1210\/clinem\/dgae088","article-title":"Treatment Satisfaction With Omnipod DASH in Adults With Type 1 Diabetes: A Nonblinded 1:1 Randomized Controlled Trial","volume":"109","author":"Kong","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026043008201203000_14.2.e005860.25","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816638674"},{"key":"2026043008201203000_14.2.e005860.26","doi-asserted-by":"publisher","DOI":"10.2337\/cd20-0022"},{"key":"2026043008201203000_14.2.e005860.27","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/dme.13412","article-title":"Comparison of different insulin pump makes under routine care conditions in adults with Type 1 diabetes","volume":"34","author":"Leelarathna","year":"2017","journal-title":"Diabet Med"},{"key":"2026043008201203000_14.2.e005860.28","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc24-S001","article-title":"1. Improving care and promoting health in populations: Standards of Care in Diabetes\u20142024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"2026043008201203000_14.2.e005860.29","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1752"},{"key":"2026043008201203000_14.2.e005860.30","doi-asserted-by":"publisher","DOI":"10.1177\/2040622314548679"},{"key":"2026043008201203000_14.2.e005860.31","doi-asserted-by":"crossref","first-page":"100137","DOI":"10.1016\/j.deman.2023.100137","article-title":"Identifying type 1 \/ type 2 diabetes in medico-administrative database to improve health surveillance, medical research and prevention in diabetes: Algorithm development and application","volume":"10","author":"Fuentes","year":"2023","journal-title":"Diabetes Epidemiology and Management"},{"key":"2026043008201203000_14.2.e005860.32","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 . Commission nationale d\u2019evaluation des dispositifs m\u00e9dicaux et des technologies de sante. 2020."}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2025-005860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:20:39Z","timestamp":1777562439000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2025-005860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4,30]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjdrc-2025-005860"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2025-005860","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}